About Avient Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

Joining Edgetek™ PKE and LubriOne™ PKE materials launched in 2021, Complēt PKE formulations can provide alternatives to nylon (PA) and acetal (POM) based formulations, offering added supply security and sustainable benefits.  

Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

Q 3 2 0 2 1 P E R F O R M A N C E U P D AT E $74 $99 2020 2021 $0.46 $0.70 2020 2021 Q3 2021 PERFORMANCE ( T O TA L C O M PA N Y ) 4 Sales Adjusted Operating Income $925 $1,220 2020 2021 + 32% Adjusted EPS + 34% + 52% (in millions) (in millions) Q3 2021 SEGMENT PERFORMANCE 5 CAI $494 $587 Sales ($ in millions) SEM Distribution $51 $67 Operating Income +19% +31% $277 $439 Sales $18 $24 Operating Income +58% +33% (1) $174 $234 Sales $25 $32 Operating Income +34% +28% SPECIALTY EBITDA MARGIN EXPANSION 6 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Color acquisition 15.3% 15.2% 16.2% 17.6% 2018 2019 2020 YTD 2021 14.8% 15.2% 17.6% 18.4% 2018 2019 2020 YTD 2021 (1) SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Color synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 7 Legacy CAI 18.9% 18.9% 19.8% 2019 2020 YTD 2021 Legacy Clariant Color 11.9% 13.8% 15.7% 2019 2020 YTD 2021 • Synergy capture driving margin improvement • Favorable mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 35% represents sales from products introduced in the last five years. D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of October 25, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. In 2021, we expect substantial earnings growth and strong cash flow generation as we emerge from the COVID-19 pandemic.

$86 $123 2020PF 2021 $0.53 $0.89 2020PF 2021 Q1 2021 – ORGANIC PERFORMANCE ( T O TA L C O M PA N Y ) 3 Sales Adjusted Operating Income $991 $1,162 2020PF 2021 + 17% Adjusted EPS + 43% + 68% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q1 2021 SEGMENT PERFORMANCE 4 CAI $536 $609 Sales ($ in millions) SEM Distribution $64 $89 Operating Income (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition +14% +39% $290 $363 Sales $19 $24 Operating Income +25% +26% (1) $185 $217 Sales $22 $34 Operating Income +17% +55% SPECIALTY EBITDA MARGIN EXPANSION 5 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 15.3% 15.2% 16.2% 19.1% 2018 2019 2020 Q1 2021 14.8% 15.2% 17.6% 19.4% 2018 2019 2020 Q1 2021 (1) SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Masterbatch synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 6 Legacy CAI 18.9% 18.9% 21.0% 2019 2020 Q1 2021 Legacy Clariant MB 11.9% 13.8% 17.4% 2019 2020 Q1 2021 • Early synergy capture translating to the bottom line • Positive mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 36% represents sales from products introduced in the last five years. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of April 27, 2021 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi e n t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of April 27, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers. In 2021, we expect substantial earnings growth and strong cash flow generation as we emerge from the COVID-19 pandemic.

Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

Launched in 2021, Mevopur™ Healthcare Bio-based Polymer Solutions are color and additive concentrates and ready-to-use formulations manufactured with bio-based polypropylene, polyethylene, polycarbonate, acrylonitrile butadiene styrene, or styrenic polymers.  

Introduced in 2021, the Mevopur portfolio also includes custom color and additive concentrates and ready-to-use formulations made with bio-based polyolefins, polycarbonate, acrylonitrile butadiene styrene, or styrenic polymers.

About Avient Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.